Shu-cheng Y. Gu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis

Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis

Journal: Zhonghua yi xue za zhi

Published: November 07, 2019

Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome.

Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome.

Journal: Oncotarget

Published: August 10, 2015

Osteogenic Differentiation Potential of Bone Marrow Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes

Osteogenic Differentiation Potential of Bone Marrow Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 29, 2015

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes.

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes.

Journal: Nature communications

Published: May 28, 2015

mRNA expression of notch ligand-delta-like-1 and jagged-1 in mesenchymal stem cells of MDS patients

mRNA expression of notch ligand-delta-like-1 and jagged-1 in mesenchymal stem cells of MDS patients

Journal: Zhongguo shi yan xue ye xue za zhi

Published: December 30, 2014

Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome.

Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome.

Journal: Scientific reports

Published: September 17, 2014

Iron chelation therapy and its influence on the alleviation of EPO resistance in MDS patients

Iron chelation therapy and its influence on the alleviation of EPO resistance in MDS patients

Journal: Zhongguo shi yan xue ye xue za zhi

Published: August 19, 2014

Study on phenotypic and cytogenetic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes

Study on phenotypic and cytogenetic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: April 25, 2013

Study of aberrant p73 promoter methylation in patients with myelodysplastic syndrome

Study of aberrant p73 promoter methylation in patients with myelodysplastic syndrome

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: February 07, 2013

Research advances of hepcidin expression and its regulation mechanism

Research advances of hepcidin expression and its regulation mechanism

Journal: Zhongguo shi yan xue ye xue za zhi

Published: August 31, 2012

Expression of p57kip2 in patients with de novo myelodysplastic syndrome and its relationship with SDF-1/CXCR4 axis

Expression of p57kip2 in patients with de novo myelodysplastic syndrome and its relationship with SDF-1/CXCR4 axis

Journal: Zhongguo shi yan xue ye xue za zhi

Published: May 01, 2012

Bone marrow mesenchymal stem cells in myelodysplastic syndromes: cytogenetic characterization.

Bone marrow mesenchymal stem cells in myelodysplastic syndromes: cytogenetic characterization.

Journal: Acta haematologica

Published: February 22, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026